↓ Skip to main content

Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis

Overview of attention for article published in Frontiers in immunology, September 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
9 X users

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis
Published in
Frontiers in immunology, September 2021
DOI 10.3389/fimmu.2021.730320
Pubmed ID
Authors

Qing Zhao, Jianwei Zhang, Lingyi Xu, Huaxia Yang, Naixin Liang, Li Zhang, Fengchun Zhang, Xuan Zhang

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 8%
Other 3 6%
Student > Postgraduate 3 6%
Student > Master 3 6%
Unspecified 2 4%
Other 8 17%
Unknown 25 52%
Readers by discipline Count As %
Medicine and Dentistry 15 31%
Unspecified 2 4%
Biochemistry, Genetics and Molecular Biology 2 4%
Chemistry 1 2%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 0 0%
Unknown 27 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2021.
All research outputs
#8,575,549
of 26,163,973 outputs
Outputs from Frontiers in immunology
#10,580
of 33,003 outputs
Outputs of similar age
#160,305
of 440,340 outputs
Outputs of similar age from Frontiers in immunology
#497
of 1,412 outputs
Altmetric has tracked 26,163,973 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 33,003 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,340 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 1,412 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.